Veradermics MANE
NYSE MANE
$117.11 -4.12 (-3.40%)
As of: Oct 1, 2026 · 3:59 PM EDT

Veradermics (MANE) Cash from Financing Activities (2025 - 2026)

Updated

Veradermics (MANE) reported Cash from Financing Activities of $442.7 million for Q2 2026, compared with $129,000 a year earlier and up 64.5% from the prior quarter.

Analysis

Veradermics (MANE) Cash from Financing Activities (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Veradermics' Cash from Financing Activities came in at $720.36 million; for FY2025, it was $159.14 million, up 163.1% from FY2024.

  • By year, Cash from Financing Activities came in at $60.48 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Veradermics 5.07 Bn 5.07 Bn - 442.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 442.70 Mn
Mar 31, 2026 269.11 Mn
Jun 30, 2025 129,000.00
Mar 31, 2025 8.42 Mn
API Access

Veradermics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MANE&period=max&api_key=YOUR_API_KEY